Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80325db0884a75d708d09a181bb84e1d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
1997-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e528a9de49157d033a63dd6cb19804a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6c793c7fe2efe319322c2470ed9c96e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_111107201d92d989d4c85d76e62f553d |
publicationDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2201766-C2 |
titleOfInvention |
Multi-specific or bispecific molecule (versions), method for elimination or decreasing quantity of target cells in subject's body, method for treating pathogen-infected subject and method for subject's vaccination |
abstract |
FIELD: medicine. SUBSTANCE: innovation deals with multi-specific compounds containing, at least, one binding determinant which binds Fc-alpha-receptors at effector cell. Another binding determinant binds one or more antigens at target cell, for example Neu/Her-2 protooncogene product or receptor of epidermal growth factor at cancer cells, or Candida antigens at infected cells. Examples are bispecific and trispecific antibodies. It is suggested both therapeutic and prophylactic application of mentioned compounds. The method enables to achieve multiple specificity in treating cancer and pathogenic infections. EFFECT: higher efficiency. 19 cl, 28 dwg |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2640082-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487888-C2 |
priorityDate |
1996-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |